drugset / Trial / NCT01181167
A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The objective of this study is to assess the efficacy and safety of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective total hip arthroplasty.
Timeline
- Start
- 2009-05
- Primary completion
- 2010-01
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Edoxaban | Small molecule | 30 mg | Oral |
| Comparator | Enoxaparin sodium | Other / unclassified | 20 mg | Subcutaneous |